KRISTIN CONSIGLIO-TAYLOR: Open Payments
NPI 1356825970 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,324 in 56 payments from 16 companies in 2025. Trend: 2023 $672 · 2024 $1,137 · 2025 $1,324
Food & beverage: $1,255Education: $69
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $281 |
| ABBVIE INC. | 7 | $186 |
| Novo Nordisk Inc | 8 | $172 |
| Astellas Pharma US Inc | 6 | $145 |
| Lilly USA, LLC | 4 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $86 |
| Amgen Inc. | 5 | $75 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| PFIZER INC. | 2 | $46 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
Products named: FARXIGA, JARDIANCE, UBRELVY, Ozempic, AIRSUPRA, QULIPTA, Veozah, MOUNJARO.
Industry payments across FL — which companies pay providers there.
